TVGN (Tevogen Bio Holdings) Scaled Net Operating Assets: -0.24 (As of Mar. 2026)


TVGN Tevogen Bio Holdings Inc TVGN
10 GF Score
Price $5.86
! 4 Warning Signs
View Full Analysis

What is Tevogen Bio Holdings Scaled Net Operating Assets?

Tevogen Bio Holdings TVGN +1.56% 10 Scaled Net Operating Assets is -0.24 as of Mar. 2026. GuruFocus rates TVGN with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tevogen Bio Holdings's operating assets for the quarter that ended in Mar. 2026 was $4.23 Mil. Tevogen Bio Holdings's operating liabilities for the quarter that ended in Mar. 2026 was $5.29 Mil. Tevogen Bio Holdings's Total Assets for the quarter that ended in Dec. 2025 was $4.38 Mil. Therefore, Tevogen Bio Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was -0.24.

Tevogen Bio Holdings Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Tevogen Bio Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tevogen Bio Holdings Scaled Net Operating Assets Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
-0.02 44.65 0.00 -0.92 -0.37

Tevogen Bio Holdings Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.41 -0.64 -0.31 -0.29 -0.24

TVGN vs GRDX, DYAI, KYNB: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Tevogen Bio Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tevogen Bio Holdings Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tevogen Bio Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Tevogen Bio Holdings's Scaled Net Operating Assets falls into.


TVGN
10GF Score
Tevogen Bio Holdings Inc TVGN
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tevogen Bio Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tevogen Bio Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(3.831-5.116)/3.462
=-0.37

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4.383 - 0.552
=3.831

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=12.618 - 5.523 - 1.979
=5.116

Tevogen Bio Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(4.229-5.29)/4.383
=-0.24

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4.921 - 0.692
=4.229

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=14.763 - 7.494 - 1.979
=5.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.24 mean?
Tevogen Bio Holdings (TVGN) has a Scaled Net Operating Assets of -0.24 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Tevogen Bio Holdings and its competitors.
Is Tevogen Bio Holdings' Scaled Net Operating Assets too high?
Tevogen Bio Holdings' current Scaled Net Operating Assets is -0.24. Overall, Tevogen Bio Holdings has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Tevogen Bio Holdings' Scaled Net Operating Assets compare to GRDX and DYAI?
Tevogen Bio Holdings' Scaled Net Operating Assets of -0.24 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Tevogen Bio Holdings and its competitors. Tevogen Bio Holdings's current Scaled Net Operating Assets is -0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tevogen Bio Holdings stock overvalued right now?
Tevogen Bio Holdings (TVGN) has a current Scaled Net Operating Assets of -0.24. The current Scaled Net Operating Assets is -0.24. Tevogen Bio Holdings' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Tevogen Bio Holdings (TVGN), the current Scaled Net Operating Assets is -0.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tevogen Bio Holdings Business Description

Address 15 Independence Boulevard, Suite 210, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
10GF Score

Get the complete analysis for TVGN

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.86
Price